http://purl.org/np/RAIm6t-GCs... RAIm6t-GCs

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0002-3668-2627 Elif Ozkan

Elif Ozkan

2022-10-10T15:19:49.777Z

http://purl.org/np/RAIm6t-GCs... RAIm6t-GCs

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-10-10T15:19:49.777614

Elif Ozkan

2022-10-10T15:19:49.777Z

http://purl.org/np/RAIm6t-GCs... RAIm6t-GCs

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

Fluticasone Furoate/Vilanterol ELLIPTA 100/25 mcg is indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. The drug is NOT indicated for relief of acute bronchospasm.

Elif Ozkan

2022-10-10T15:19:49.777Z